早期和晚期在患有败血症休克的患者中进行的诺尔上腺素的比较:系统性审查和元分析
Chiwon Ahn1, Gina Yu2, Tae Gun Shin3
1Department of Emergency Medicine, College of Medicine, Chung-Ang University, Seoul, South Korea.
Chest
|July 7, 2024
概括
在败血症休克中早期使用诺拉上腺素不会显著改变整体死亡率. 然而,在特定的流体管理策略下,它可能会减少肺并改善存活率.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 在败血症休克中服用血管压缩剂的最佳时机至关重要,但仍有争议.
- 上腺素是用于治疗败血症休克的关键血管压缩剂.
研究的目的:
- 为了调查早期与晚期的诺拉上腺素给药是否会影响败血症休克的预后.
- 分析北上腺素定时治疗对死亡率和其他临床结果的影响.
主要方法:
- 一个系统的综述和对比早期和晚期的诺阿基尼林在成人败血症患者的研究的元分析.
- 包括随机对照试验 (RCT) 和通过全面的数据库搜索确定的观察性研究.
- 主要结局是整体死亡率;次要结局包括ICU停留时间,无呼吸器日和不良事件.
主要成果:
- 对12项研究 (7,281名患者) 的分析表明,在RCT或观察性研究中,在早期和晚期的诺亚上腺素组之间,整体死亡率没有显著差异.
- 在没有限制性流体策略的RCT中,早期的诺亚上腺素与较低的死亡率有关.
- 在特定研究子组中,早期服用与无呼吸器日数增加和肺发病率降低相关.
结论:
- 败血性休克的整体死亡率不会受到北上腺素的时间的显著影响.
- 早期的上腺素可能有助于减少肺水腫和提高存活率,当液体复苏不那么强调时.
- 进一步的研究可能会根据流体管理协议澄清最佳时间.
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
764
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
764
01:27Adrenergic Neurons: Neurotransmission
3.6K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.6K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57